How should we treat recurrent hepatitis C after liver transplantation?
- 30 April 2005
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (4) , 462-468
- https://doi.org/10.1016/j.jhep.2005.01.013
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-upTransplantation, 2004
- A Model to Predict Severe Hcv–Related Disease Following Liver TransplantationHepatology, 2003
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- Treatment of recurrent hepatitis c virus infection after liver transplantation with interferon and ribavirinTransplantation Proceedings, 1998
- Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferonLiver Transplantation and Surgery, 1998
- A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantationHepatology, 1998
- Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantationHepatology, 1997
- An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejectionHepatology, 1995
- Interferon–α Therapy for Hepatitis C Virus Infection After Liver TransplantationHepatology, 1994
- PRELIMINARY EXPERIENCE WITH α-2b-INTERFERON THERAPY OF VIRAL HEPATITIS IN LIVER ALLOGRAFT RECIPIENTS1,2Transplantation, 1992